top of page
Nelson Advisors > European HealthTech & MedTech


This Week in European MedTech and HealthTech: 13th March 2026
European HealthTech this week is dominated by EU‑level regulatory moves around MDR/IVDR and AI, plus a clear pivot of digital health from “experiments” to scaled implementation and validation funding. European MedTech this week is centred on the EU “Health Package” (MDR/IVDR reset plus biotech/clinical trials tweaks), upcoming Commission discussions on devices, and a continued narrative of consolidation and “compliance‑driven” strategy.
Mar 136 min read


Nelson Advisors 2026 Video of Market Predictions, Insights and Observations in HealthTech, MedTech and Digital Health
Nelson Advisors 2026 Video of Market Predictions, Insights and Observations in HealthTech, MedTech and Digital Health.
Dec 31, 20251 min read


Who are the leading boutique investment banks advising European Digital Health founders and Venture Capital funded companies?
The Specialist Boutiques: Firms like Nelson Advisors and Clipperton offer highly targeted, domain-specific expertise. They often cater to founder-led exits and specific verticals like Health IT, MedTech, and AI, providing a level of operational empathy and sector nuance that larger firms cannot provide.
Dec 12, 202514 min read


Nelson Advisors LLP: Profile of a European Healthcare Technology M&A Specialist
Nelson Advisors LLP, a UK-based firm, is explicitly and exclusively focused on providing mergers and acquisitions (M&A) advisory services within the healthcare technology sector across the United Kingdom, Europe, and North America. The firm’s core value proposition is rooted in a distinctive "practitioner-led" approach. This model is a direct function of the synergistic partnership between its two co-founders, whose professional backgrounds combine extensive corporate finance
Sep 13, 20257 min read


Nelson Advisors' Role in UK Market Entry Strategies
This report provides a comprehensive analysis of Nelson Advisors LLP, a highly specialised London-based M&A and corporate advisory firm, and its strategic role in assisting healthcare technology (HealthTech) and MedTech companies with UK market entry.
A central finding is the firm's use of a "Build, Buy, Partner, Sell" framework, which transcends traditional transactional advisory. This holistic model guides clients, particularly Western European and North American compan
Aug 22, 202510 min read
bottom of page